Lipid abnormalities in end stage renal disease

被引：55

作者：

Oda, H ^{[1
]}

Keane, WF ^{[1
]}

机构：

[1] Univ Minnesota, Hennepin Cty Med Ctr, Sch Med, Dept Med, Minneapolis, MN 55415 USA

来源：

NEPHROLOGY DIALYSIS TRANSPLANTATION | 1998年 / 13卷

关键词：

atherosclerosis; end stage renal disease; fibrate; hypercholesterolemia; hypertriglyceridemia; 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor;

D O I：

10.1093/ndt/13.suppl_1.45

中图分类号：

R3 [基础医学]; R4 [临床医学];

学科分类号：

1001 ; 1002 ; 100602 ;

摘要：

引用

页码：45 / 49

页数：5

共 58 条

[1]

ALSAYED N, 1991, CLIN CHEM, V37, P387

[2] Increased activity of plasma cholesteryl ester transfer protein in children with end-stage renal disease receiving continuous ambulatory peritoneal dialysis [J].

Asayama, K ;

Hayashibe, H ;

Mishiku, Y ;

Honda, M ;

Ito, H ;

Nakazawa, S .

NEPHRON, 1996, 72 (02) :231-236

[3] LIPOPROTEIN METABOLISM AND RENAL-FAILURE [J].

ATTMAN, PO ;

SAMUELSSON, O ;

ALAUPOVIC, P .

AMERICAN JOURNAL OF KIDNEY DISEASES, 1993, 21 (06) :573-592

[4]

BACHMANN J, 1995, J AM SOC NEPHROL, V6, P121

[5] LIPOPROTEIN (A) LEVELS IN END-STAGE RENAL-FAILURE AND RENAL-TRANSPLANTATION [J].

BARBAGALLO, CM ;

AVERNA, MR ;

SPARACINO, V ;

GALIONE, A ;

CAPUTO, F ;

SCAFIDI, V ;

AMATO, S ;

MANCINO, C ;

CEFALU, AB ;

NOTARBARTOLO, A .

NEPHRON, 1993, 64 (04) :560-564

[6]

BELLAZZI R, 1993, ADV PERIT D, V9, P312

[7] THE INFLUENCE OF CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS ON PLASMA-LIPOPROTEINS [J].

BRECKENRIDGE, WC ;

RONCARI, DAK ;

KHANNA, R ;

OREOPOULOS, DG .

ATHEROSCLEROSIS, 1982, 45 (03) :249-258

[8]

CHAN MK, 1982, CLIN NEPHROL, V17, P183

[9] PLASMA LECITHIN-CHOLESTEROL ACYLTRANSFERASE ACTIVITIES IN UREMIC PATIENTS [J].

CHAN, MK ;

RAMDIAL, L ;

VARGHESE, Z ;

PERSAUD, JW ;

BAILLOD, RA ;

MOORHEAD, JF .

CLINICA CHIMICA ACTA, 1982, 119 (1-2) :65-72

[10] LIPID ABNORMALITIES IN UREMIA, DIALYSIS, AND TRANSPLANTATION [J].

CHAN, MK ;

VARGHESE, Z ;

MOORHEAD, JF .

KIDNEY INTERNATIONAL, 1981, 19 (05) :625-637

← 1 2 3 4 5 6 →